NIH Director: There’s a Big Push to Increase Production of GSK Vir Monoclonal Antibody, the Only One Effective Against Omicron

NIH Director Dr. Francis Collins told CBS’ “Face the Nation” on Sunday that there’s a big push on the production of GSK Vir monoclonal antibodies, particularly for people at high risk, because it’s the most effective antibody treatment to fight against the Omicron variant. Read Full Story